Treatments for Type 2 Diabetes
Savranthi Madala, MD, PhD. Endocrinology Specialist at AristaMD
Treatment for type two diabetes: there are many different ways to attack type two diabetes, and we’ll go through each of these in detail, but just a general overview. To help our pancreas increase the secretion of insulin, there are the Sulur Glide and Incretin for it to help the liver decrease the glucagon secretion. Glucagon glucagon is a counter-regulatory hormone that increases blood sugar. There are the incretin and amylin and the medications that control your appetite are the incretins and amylin. Incretin are your ozempic, your tirzepatide, your GLP one agonist. And here, down in the kidney to, to decrease the reabsorption of glucose from the urine are the SGLT two inhibitors such as Jardiance and recana and farxiga. Then in the muscles to increase the uptake in the utilization of insulin are our TCDs, which is actose, and metformin. then to decrease lipotoxicity are your TCDs and salicylates. And to decrease hepatic glucose output are metformin and TCDs. And then in the GI system, there’s so many that act in the GI system itself. The incretin are the main ones. Um, and we’ll go over the incretin effect in a few, few sides and what that actually is. And the alpha glucco inhibitors, amylin, and bile acid se questions, but they’re, those aren’t really used anymore like coce. They’re not first-line therapy due to the side effect profile.
Five Ways eConsults Support Value-Based Care
Combine your referral management platform with an eConsult solution to reduce patient wait times and the cost of care. Learn five ways our eConsults support value-based care by allowing primary care physicians, nurse practitioners or PAs to submit electronic requests for patient advice to our team of specialists to manage low-acuity patients.
#1 Help Patients Avoid Unnecessary Face-to-Face Specialty Visits
About 70% of eConsults can address what physicians typically send for a face-to-face specialty visit. As a web-based physician-to-physician consultation, there is no need for any particular technology or integration — the PCP orders the referral the same way they would traditionally order one. Or suppose the patient was to go face-to-face for a specialty consult with the provider using our referral nurse coordination, RNN service, and nurse navigators. In that case, our nurse will curate the eConsults by grabbing all of the data needed for the patient from the chart. Private health information is then sent to our specialist, who reviews the data and provides an evidence-based response on that patient’s best practice and management. Within four to six hours, the primary care provider receives a notification and can view the eConsult specialist’s recommendations.
The bottom line — for every specialty visit where we serve the patient using an eConsult and address issues through the primary care provider, we can fend off the need for three face-to-face visits. Also, once you gain specific knowledge from a specialist on a particular condition, you have the answer to the same question when it comes up again.
Savranthi Madala, MD, PhD
Endocrinology Specialist at AristaMD
Savranthi Madala, MD, PhD, is Board Certified in Internal Medicine and fellowship-trained in endocrinology. She attended medical school at the Medical College of Virginia followed by residency at the University of Connecticut Medical Center. Dr. Madala completed her fellowship in endocrinology at the Warren Alpert Medical School of Brown University.